Sign in

CIK 0000318306

  • Non-accelerated filer
  • Smaller reporting company

ABEONA THERAPEUTICS INC.

Sign in to watch
Ticker
ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
830221517
Phone
+1 646-813-4701
Business address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
Former names
PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 38,590 shares (grant or award)
  2. 4 Grant or award Director acquired 77,181 shares (grant or award)
  3. 4 Grant or award Director acquired 38,590 shares (grant or award)
  4. 4 Grant or award Director acquired 77,181 shares (grant or award)
  5. 4 Grant or award Director acquired 38,590 shares (grant or award)
  6. 4 Grant or award Director acquired 77,181 shares (grant or award)
  7. 4 Open-market sale Director sold 80,000 shares at $2.01 ($160,888)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Chief Accounting Officer sold 55,445 shares at an average $1.82 ($100,712)
  13. 4 Open-market sale Chief Executive Officer sold 45,409 shares at $1.87 ($84,919)
  14. 4 Grant or award Chief Executive Officer acquired 250,000 shares (grant or award)
  15. 4 Open-market sale Director sold 80,000 shares at $2.23 ($178,624)
  16. 4 Grant or award Chief Operating Officer acquired 200,000 shares (grant or award)
  17. 4 Grant or award Chief Accounting Officer acquired 50,000 shares (grant or award)
  18. 4 Open-market sale Director sold 45,566 shares at $2.38 ($108,502)
  19. 4 Open-market sale Director sold 251,625 shares at $2.39 ($601,057)
  20. 4 Open-market sale Director sold 132,664 shares at $2.34 ($310,168)

Page 11 of 20 · 394 filings